Effect of 0.5% apraclonidine on ptosis in Horner syndrome

Ophthalmic Plastic and Reconstructive Surgery

Volumn 22, Issue 1, 2006, Pages 53-55

  Garibaldi, Daniel C ^a   Hindman, Holly B ^a   Grant, Michael P ^a   Iliff, Nicholas T ^a   Merbs, Shannath L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DRUG DERIVATIVE; EYE DROPS;

ADULT; AGED; ANISOCORIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EYE SWELLING; EYELID; HEADACHE; HORNER SYNDROME; HUMAN; JAW; MALE; MAXILLARY SINUS; MIOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIORITY JOURNAL; PTOSIS; PUPIL; THORAX; DOSE RESPONSE; DRUG INSTILLATION; FOLLOW UP; MIDDLE AGED;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; ANISOCORIA; BLEPHAROPTOSIS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HORNER SYNDROME; HUMANS; INSTILLATION, DRUG; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS;

EID: 33645218027     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000196322.05586.6a     Document Type: Article

References (5)

1. Morales J, Brown SM, Abdul-Rahim AS, et al. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol 2000;118:951-4.
2. Brown SM, Aouchiche R, Freedman KA. The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch Ophthalmol 2003;121:1201-3.
3. Bacal DA, Levy SR. The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch Ophthalmol 2004;122:276-9.
4. Freedman KA, Brown SM. Topical apraclonidine in the diagnosis of suspected Horner syndrome. J Neuroophthal 2005;25:83-5.
5. Esmaeli-Gutstein B, Hewlett BR, Pashby RC, et al. Distribution of adrenergic receptor subtypes in the retractor muscles of the upper eyelid. Ophthal Plast Reconstr Surg 1999;15:92-9.